바이젠셀
5,040KRWMarket close of 10/28 (Wed)
Down -0.59%-30KRWMarket close of 10/28 (Wed)
- Open
- 5,250
- High
- 5,250
- Low
- 4,975
- Day range
- Day range low 4,975 high 5,250, open 5,250, close 5,040, previous close 5,070
- Volume
- 10×10K shares
- 512.07 million KRW 1.12× the 20-session average
Market close of 10/28 (Wed)
Where it sits in the 1-year range
15%1-year close range 3,090 to 15,800 won, 15% up from the low
15% of the way up from the lowest close in 1 year (252 sessions) · -68.1% from the high
Loading
Free · no sign-inSource from 2021-05-17
Data dateMost recent closing data10/28 (Wed)
Market close data of 2026-10-28Points to check
- Earningsto check-13.6B KRWOperating income over the last four quarters -13.6B KRW (loss)
- Recent filingsnot verifiedOutside filing data coverage, so not verified
- Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
The other 2 are within the usual range
- Daily move-0.59%usual range
- Trading value1.1×usual range
See the full check report
Quarterly results · Q1 2025
- Revenue0 KRW
- vs. year ago
- —
- vs. prior quarter
- -100.0%
- Operating income-2.7B KRW
- vs. year ago
- Still a loss
- vs. prior quarter
- Still a loss
Quarterly operating income trend
As of the latest official close · 2026-10-28Valuation filing date · 2025-05-15Same sector · 바이오 R&D
Up +1.90%· 40 of 64 stocks up, preferred shares excluded · trading value 209.6B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 알테오젠 | Close over the last 20 sessions -12.0% | Up +2.06% | 52.9B KRW |
| 디앤디파마텍 | Close over the last 20 sessions +2.3% | Up +5.15% | 28.1B KRW |
| 올릭스 | Close over the last 20 sessions -5.4% | Up +7.40% | 22.0B KRW |
| 리가켐바이오 | Close over the last 20 sessions -16.7% | Up +3.60% | 13.4B KRW |
| 프로티나 | Close over the last 20 sessions -3.9% | Up +5.21% | 10.3B KRW |
Schedule
- Next data 10/30 (Fri) after 08:50
Related news
Loading
Tables, financials, investor flows and filing history are in the Detailed view.
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 83% of trading value, about 93% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.